Eyeing A 6.84% Potential Upside In The Healthcare Sector
Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the ophthalmic industry, has long been a beacon for innovation in eye health. With a market capitalization of $5.08 billion, the company is a key player in the healthcare sector, specifically in medical instruments and supplies. Headquartered in Vaughan, Canada, Bausch + Lomb operates globally, providing a broad spectrum of products ranging from contact lenses to complex surgical devices.
The company’s current stock price stands at $14.32 per share, facing a slight dip of 0.01% recently. However, with a 52-week range fluctuating between $10.90 and $20.93, the stock presents an intriguing narrative for investors. The average target price from analysts suggests a potential…
